All News

Results from the PALISADE study were published in The New England Journal of Medicine.

The vaccine, VAX-31, targets 20 serotypes in common with PCV20, as well as 11 additional serotypes.

Results from HERCULES will form the basis for future discussions with global regulatory authorities, according to Sanofi.

The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 strain.

Catch up on important immunization news from the month of August.

In case you missed it, this week we had news about COVID-19 and the upcoming respiratory virus season, advancements in clinical trials for ASCVD, the first OTC birth control, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around the importance of COVID-19 vaccines.

Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.

Checkout these important FDA updates from the month of August 2024.

Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.

Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.

As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.

Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.

Don’t miss out on the latest pharmacy insights in the Drug Topics July/August issue.

Check out this list of our top 10 stories from August 2024.

Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around COVID-19 vaccination and how to help patients overcome vaccine hesitancy.

Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”

Check out these top featured stories from Drug Topics in August 2024.

The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Check out these featured Drug Topics interviews from August 2024.

Don’t miss out on the latest pharmacy insights in the Total Pharmacy June issue.

In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.